Skip to content
healthcare.dev

Gavreto

NDC 71332-006, Pralsetinib, capsule, from Rigel Pharmaceuticals, Inc..

Product NDC
71332-006
Status
Listed
Labeler
Rigel Pharmaceuticals, Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA213721
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71332-006 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PRALSETINIB100 mg/1

Pharmacologic classes

Kinase Inhibitor [EPC]; Rearranged during Transfection (RET) Inhibitors [MoA]

Package NDCNDC-11Package
71332-006-1271332000612120 CAPSULE in 1 BOTTLE (71332-006-12)
71332-006-607133200066060 CAPSULE in 1 BOTTLE (71332-006-60)
71332-006-907133200069090 CAPSULE in 1 BOTTLE (71332-006-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/16edd46e-28b8-f06d-e063-6394a90ae31b

Use it

Look up 71332-006 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71332-006 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71332-006. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.